GSK (GSK)
51.06
+1.34 (2.70%)
Upcoming Events
Latest Headlines
Form 6-K GSK plc For: Jun 01
June 1, 2026 10:46 AM - SEC Filing
Form 6-K GSK plc For: Jun 01
June 1, 2026 10:00 AM - SEC Filing
PrEP Wisdom: ViiV Healthcare Launches New Campaign to Support Informed HIV Prevention Choices
June 1, 2026 8:00 AM - BizWire
Form 6-K GSK plc For: May 28
May 28, 2026 6:06 AM - SEC Filing
Form 6-K GSK plc For: May 27
May 27, 2026 10:34 AM - SEC Filing
Form SD GSK plc
May 26, 2026 4:22 PM - SEC Filing
Form 6-K GSK plc For: May 26
May 26, 2026 10:24 AM - SEC Filing
Form 6-K GSK plc For: May 26
May 26, 2026 10:17 AM - SEC Filing
Kepler Cheuvreux Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy
May 26, 2026 3:55 AM - StreetInsider
Form 6-K GSK plc For: May 22
May 22, 2026 7:19 AM - SEC Filing
Form 6-K GSK plc For: May 20
May 20, 2026 10:41 AM - SEC Filing
Form 6-K GSK plc For: May 20
May 20, 2026 10:39 AM - SEC Filing
Form 6-K GSK plc For: May 19
May 19, 2026 11:01 AM - SEC Filing
Form 6-K GSK plc For: May 18
May 18, 2026 11:04 AM - SEC Filing
Form 6-K GSK plc For: May 18
May 18, 2026 6:30 AM - SEC Filing
Form 13F-HR GSK plc For: Mar 31
May 14, 2026 4:46 PM - SEC Filing
Form 6-K GSK plc For: May 14
May 14, 2026 12:23 PM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP25 at Jefferies
May 14, 2026 4:13 AM - StreetInsider
This European pharma company's next three months are catalyst-rich: Bernstein
May 14, 2026 2:30 AM - StreetInsider
Form 6-K GSK plc For: May 11
May 11, 2026 10:59 AM - SEC Filing
Form 6-K GSK plc For: May 11
May 11, 2026 6:43 AM - SEC Filing
Form 6-K GSK plc For: May 11
May 11, 2026 6:31 AM - SEC Filing
Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
May 7, 2026 8:00 AM - BizWire
Form 6-K GSK plc For: May 06
May 6, 2026 1:52 PM - SEC Filing
Form SCHEDULE 13G GSK plc Filed by: FMR LLC
May 6, 2026 11:19 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP21 at Citi
May 6, 2026 5:35 AM - StreetInsider
Form 6-K GSK plc For: May 05
May 5, 2026 12:54 PM - SEC Filing
Form 6-K GSK plc For: May 01
May 1, 2026 11:11 AM - SEC Filing
Form 6-K GSK plc For: May 01
May 1, 2026 11:09 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP18 at Barclays
April 30, 2026 5:45 AM - StreetInsider
Form 6-K GSK plc For: Apr 29
April 29, 2026 12:01 PM - SEC Filing
Form 6-K GSK plc For: Apr 29
April 29, 2026 8:10 AM - SEC Filing
The Fifth International Healthcare Week set for next month
April 29, 2026 4:59 AM - StreetInsider
Increasing unusual call option volume: KOPN ERAS OGN FEZ VAL SANM GSK RMBS
April 29, 2026 4:30 AM - StreetInsider
GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.47
April 29, 2026 3:24 AM - StreetInsider
GSK (GSK) spreader of 18K contracts of May 56 calls, 12K contracts of May 60 calls and 12K contracts of May 51 puts
April 28, 2026 2:58 PM - StreetInsider
GSK (GSK) spreader of 18K contracts of May 56 calls, 12K contracts of May 60 calls and 12K contracts of May 51 puts
April 28, 2026 2:46 PM - StreetInsider
Form 6-K GSK plc For: Apr 28
April 28, 2026 11:19 AM - SEC Filing
Form 6-K GSK plc For: Apr 28
April 28, 2026 7:24 AM - SEC Filing
Form 6-K GSK plc For: Apr 27
April 27, 2026 8:13 AM - SEC Filing
Form 6-K GSK plc For: Apr 27
April 27, 2026 6:59 AM - SEC Filing
Form 6-K GSK plc For: Apr 24
April 24, 2026 11:20 AM - SEC Filing
Form 6-K GSK plc For: Apr 23
April 23, 2026 6:05 AM - SEC Filing
Form 6-K GSK plc For: Apr 22
April 22, 2026 6:11 AM - SEC Filing
Form 6-K GSK plc For: Apr 21
April 21, 2026 6:05 AM - SEC Filing
Form 6-K GSK plc For: Apr 20
April 20, 2026 12:47 PM - SEC Filing
Form 6-K GSK plc For: Apr 20
April 20, 2026 6:37 AM - SEC Filing
Form 6-K GSK plc For: Apr 20
April 20, 2026 6:20 AM - SEC Filing
Form 6-K GSK plc For: Apr 17
April 17, 2026 6:16 AM - SEC Filing
Form 6-K GSK plc For: Apr 16
April 16, 2026 1:01 PM - SEC Filing
Form 6-K GSK plc For: Apr 16
April 16, 2026 6:43 AM - SEC Filing
Form 6-K GSK plc For: Apr 15
April 15, 2026 6:39 AM - SEC Filing
Form 6-K GSK plc For: Apr 15
April 15, 2026 6:16 AM - SEC Filing
Form 6-K GSK plc For: Apr 14
April 14, 2026 11:22 AM - SEC Filing
Form 6-K GSK plc For: Apr 14
April 14, 2026 6:46 AM - SEC Filing
GlaxoSmithKline (GSK) PT Raised to $67.10 at Jefferies
April 14, 2026 2:50 AM - StreetInsider
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBp25 at Jefferies
April 14, 2026 2:43 AM - StreetInsider
Form 6-K GSK plc For: Apr 13
April 13, 2026 11:18 AM - SEC Filing
Form 6-K GSK plc For: Apr 13
April 13, 2026 6:24 AM - SEC Filing
Form 6-K GSK plc For: Apr 13
April 13, 2026 6:10 AM - SEC Filing
Form 6-K GSK plc For: Apr 10
April 10, 2026 11:54 AM - SEC Filing
The Time to Talk about HIV is Now: ViiV Healthcare Launches "Still Here" PSA to Ignite Action Around HIV on National Youth HIV/AIDS Awareness Day
April 10, 2026 8:00 AM - BizWire
Form 6-K GSK plc For: Apr 10
April 10, 2026 6:51 AM - SEC Filing
GSK nixes application for drug touted by Trump for autism - WSJ
April 9, 2026 3:13 PM - StreetInsider
Form 6-K GSK plc For: Apr 09
April 9, 2026 12:39 PM - SEC Filing
Form 6-K GSK plc For: Apr 09
April 9, 2026 6:28 AM - SEC Filing
Form 6-K GSK plc For: Apr 08
April 8, 2026 8:07 AM - SEC Filing
Form 6-K GSK plc For: Apr 08
April 8, 2026 8:02 AM - SEC Filing
Form 6-K GSK plc For: Apr 07
April 7, 2026 12:50 PM - SEC Filing
Form 6-K GSK plc For: Apr 02
April 2, 2026 7:36 AM - SEC Filing
Form 6-K GSK plc For: Apr 01
April 1, 2026 12:50 PM - SEC Filing
Form 6-K GSK plc For: Apr 01
April 1, 2026 12:27 PM - SEC Filing
Form 6-K GSK plc For: Apr 01
April 1, 2026 6:59 AM - SEC Filing
Form 6-K GSK plc For: Apr 01
April 1, 2026 6:38 AM - SEC Filing
Form 6-K GSK plc For: Mar 31
March 31, 2026 6:21 AM - SEC Filing
Form 6-K GSK plc For: Mar 30
March 30, 2026 6:50 AM - SEC Filing
Form 6-K GSK plc For: Mar 30
March 30, 2026 6:36 AM - SEC Filing
Form 6-K GSK plc For: Mar 30
March 30, 2026 6:24 AM - SEC Filing
Form 6-K GSK plc For: Mar 27
March 27, 2026 7:44 AM - SEC Filing
Form 6-K GSK plc For: Mar 27
March 27, 2026 7:38 AM - SEC Filing
Form 6-K GSK plc For: Mar 26
March 26, 2026 7:07 AM - SEC Filing
Form 6-K GSK plc For: Mar 25
March 25, 2026 1:08 PM - SEC Filing
Form 6-K GSK plc For: Mar 25
March 25, 2026 9:24 AM - SEC Filing
Form 6-K GSK plc For: Mar 25
March 25, 2026 6:59 AM - SEC Filing
Form 6-K GSK plc For: Mar 24
March 24, 2026 7:39 AM - SEC Filing
Form 6-K GSK plc For: Mar 23
March 23, 2026 12:01 PM - SEC Filing
Form 6-K GSK plc For: Mar 23
March 23, 2026 11:22 AM - SEC Filing
Form 6-K GSK plc For: Mar 23
March 23, 2026 8:00 AM - SEC Filing
Form 6-K GSK plc For: Mar 23
March 23, 2026 7:49 AM - SEC Filing
Form 6-K GSK plc For: Mar 20
March 20, 2026 7:13 AM - SEC Filing
Form 6-K GSK plc For: Mar 19
March 19, 2026 10:01 AM - SEC Filing
GSK wins FDA approval for first drug treating liver disease itch
March 19, 2026 8:22 AM - StreetInsider
US FDA approves GSK's drug for liver disease related itching
March 19, 2026 8:13 AM - StreetInsider
Form 6-K GSK plc For: Mar 19
March 19, 2026 7:17 AM - SEC Filing
Form 6-K GSK plc For: Mar 18
March 18, 2026 12:51 PM - SEC Filing
Form 6-K GSK plc For: Mar 18
March 18, 2026 8:43 AM - SEC Filing
Form 6-K GSK plc For: Mar 17
March 17, 2026 2:36 PM - SEC Filing
Form 6-K GSK plc For: Mar 17
March 17, 2026 7:21 AM - SEC Filing
US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
March 16, 2026 3:46 PM - StreetInsider
Form 6-K GSK plc For: Mar 16
March 16, 2026 8:20 AM - SEC Filing
FDA expands GSK's AREXVY vaccine approval to adults 18-49 at risk
March 13, 2026 11:46 AM - StreetInsider
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
March 13, 2026 11:44 AM - BizWire
Form 6-K GSK plc For: Mar 13
March 13, 2026 8:14 AM - SEC Filing
Form 6-K GSK plc For: Mar 13
March 13, 2026 7:08 AM - SEC Filing
Form 6-K GSK plc For: Mar 12
March 12, 2026 1:15 PM - SEC Filing
Form 6-K GSK plc For: Mar 12
March 12, 2026 8:25 AM - SEC Filing
Form 6-K GSK plc For: Mar 11
March 11, 2026 7:39 AM - SEC Filing
Myriad Venture Partners adds 12 executives to advisory board
March 11, 2026 6:00 AM - StreetInsider
Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production
March 11, 2026 6:00 AM - PR NewsWire
Morgan Stanley Reiterates Underweight Rating on GlaxoSmithKline (GSK:LN) (GSK): "risk/reward skewed to downside"
March 10, 2026 12:04 PM - StreetInsider
Form 6-K GSK plc For: Mar 10
March 10, 2026 7:53 AM - SEC Filing
Form 6-K GSK plc For: Mar 09
March 9, 2026 11:58 AM - SEC Filing
Form 6-K GSK plc For: Mar 09
March 9, 2026 8:21 AM - SEC Filing
Form 6-K GSK plc For: Mar 09
March 9, 2026 8:02 AM - SEC Filing
Form 6-K GSK plc For: Mar 06
March 6, 2026 10:09 AM - SEC Filing
Form IRANNOTICE GSK plc
March 6, 2026 9:20 AM - SEC Filing
Form 20-F GSK plc For: Dec 31
March 6, 2026 9:13 AM - SEC Filing
Form 6-K GSK plc For: Mar 06
March 6, 2026 7:04 AM - SEC Filing
Full Article List
